aTyr raises $76M in series E

aTyr Pharma Inc. (San Diego, Calif.) raised $76 million in a series E round led by new investors Sofinnova Ventures and an undisclosed institutional investor. Other new investors included funds and accounts advised by T. Rowe Price; Federated Investors; Deerfield; Rock Springs Capital; EcoR1 Capital; Sphera Global Healthcare; and two more undisclosed institutional investors.

aTyr said existing investors, including VCs and a public investment fund, also participated, but did not specify which ones. Its prior investors include Alta Partners, Cardinal Partners, Domain Associates and Polaris Partners (see BioCentury, Aug. 5, 2013). ...